The purpose of this study is to measure the safety, tolerability, and the way the body absorbs, distributes, and metabolises AZD2389 as compared to placebo in participants with liver fibrosis and compensated cirrhosis. The study will also examine how the drug acts on the body
Liver Fibrosis, Hepatic Cirrhosis
The purpose of this study is to measure the safety, tolerability, and the way the body absorbs, distributes, and metabolises AZD2389 as compared to placebo in participants with liver fibrosis and compensated cirrhosis. The study will also examine how the drug acts on the body
A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.
-
Research Site, Chandler, Arizona, United States, 85224
Research Site, Rialto, California, United States, 92377
Research Site, Atlanta, Georgia, United States, 30349
Research Site, Morehead City, North Carolina, United States, 28557
Research Site, Houston, Texas, United States, 77079
Research Site, San Antonio, Texas, United States, 78215
Research Site, San Antonio, Texas, United States, 78229
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
AstraZeneca,
2025-12-08